KOR

e-Article

Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.
Document Type
Article
Source
Blood Cancer Journal; Jan2022, Vol. 12 Issue 1, p1-6, 6p
Subject
HUMORAL immunity
HEMATOLOGIC malignancies
IMMUNE response
SARS-CoV-2
INFECTION
Language
ISSN
20445385
Abstract
Copyright of Blood Cancer Journal is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)